» Articles » PMID: 32581721

Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke

Overview
Specialty Cell Biology
Date 2020 Jun 26
PMID 32581721
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Stroke is one of the major devastating diseases with no effective medical therapeutics. Because of the high rate of disability and mortality among stroke patients, new treatments are urgently required to decrease brain damage following a stroke. In recent years, the inflammasome is a novel breakthrough point that plays an important role in the stroke, and the inhibition of inflammasome may be an effective method for stroke treatment. Briefly, inflammasome is a multi-protein complex that causes activation of caspase-1 and subsequent production of pro-inflammatory factors including interleukin (IL)-18 and IL-1β. Among them, the NLRP3 inflammasome is the most typical inflammasome, which can detect cell damage and mediate inflammatory response to tissue damage in ischemic stroke. The NLRP3 inflammasome has become a key mediator of post-ischemic inflammation, leading to a cascade of inflammatory reactions and cell death eventually. Thus, NLRP3 inflammasome is an ideal therapeutic target due to its important role in the inflammatory response after ischemic stroke. In this mini review article, we will summarize the structure, assembly, and regulation of NLRP3 inflammasome, the role of NLRP3 inflammasome in ischemic stroke, and several treatments targeting NLRP3 inflammasome in ischemic stroke. The further understanding of the mechanism of NLRP3 inflammasome in patients with ischemic stroke will provide novel targets for the treatment of cerebral ischemic stroke patients.

Citing Articles

The interplay between ferroptosis and inflammation: therapeutic implications for cerebral ischemia-reperfusion.

He Y, Wang J, Ying C, Xu K, Luo J, Wang B Front Immunol. 2024; 15:1482386.

PMID: 39582857 PMC: 11583640. DOI: 10.3389/fimmu.2024.1482386.


ROS exhaustion reverses the effects of hyperbaric oxygen on hemorrhagic transformation through reactivating microglia in post-stroke hyperglycemic mice.

Guo Y, Liu J, Du X, Qi M, She T, Xue K Sci Rep. 2024; 14(1):21410.

PMID: 39271781 PMC: 11399301. DOI: 10.1038/s41598-024-72454-4.


The ability of microRNAs to regulate the immune response in ischemia/reperfusion inflammatory pathways.

Artimovic P, Spakova I, Macejkova E, Pribulova T, Rabajdova M, Marekova M Genes Immun. 2024; 25(4):277-296.

PMID: 38909168 PMC: 11327111. DOI: 10.1038/s41435-024-00283-6.


Detection of inflammasome activation in liver tissue during the donation process as potential biomarker for liver transplantation.

Mateo S, Vidal-Correoso D, Munoz-Morales A, Jover-Aguilar M, Alconchel F, de la Pena J Cell Death Discov. 2024; 10(1):266.

PMID: 38816358 PMC: 11139956. DOI: 10.1038/s41420-024-02042-y.


The Role of Beta2-Microglobulin in Central Nervous System Disease.

Liu Z, Tang F, Yang J, Chen X, Wang Z, Li Z Cell Mol Neurobiol. 2024; 44(1):46.

PMID: 38743119 PMC: 11093819. DOI: 10.1007/s10571-024-01481-6.


References
1.
ODonnell M, Xavier D, Liu L, Zhang H, Chin S, Rao-Melacini P . Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010; 376(9735):112-23. DOI: 10.1016/S0140-6736(10)60834-3. View

2.
de Almeida L, Khare S, Misharin A, Patel R, Ratsimandresy R, Wallin M . The PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory Disease. Immunity. 2015; 43(2):264-76. PMC: 4666005. DOI: 10.1016/j.immuni.2015.07.018. View

3.
Tschopp J, Schroder K . NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?. Nat Rev Immunol. 2010; 10(3):210-5. DOI: 10.1038/nri2725. View

4.
Hong P, Gu R, Li F, Xiong X, Liang W, You Z . NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. J Neuroinflammation. 2019; 16(1):121. PMC: 6554993. DOI: 10.1186/s12974-019-1498-0. View

5.
Chen K, Demarco B, Heilig R, Shkarina K, Boettcher A, Farady C . Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly. EMBO J. 2019; 38(10). PMC: 6517827. DOI: 10.15252/embj.2019101638. View